-+ 0.00%
-+ 0.00%
-+ 0.00%

Pharming Raises FY2025 Sales Guidance from $335.000M-$350.000M to $365.000M-$375.000M vs $339.625M Est

Benzinga·11/06/2025 08:19:42
Listen to the news
Pharming (NASDAQ:PHAR) raises FY2025 sales outlook from $335.000 million-$350.000 million to $365.000 million-$375.000 million vs $339.625 million estimate.